眼科医疗设备公司RxSight（股票代码：RXST）今日盘前股价暴跌36.28%，引发市场广泛关注。这一大幅下跌主要源于公司下调了2025年销售预期，以及公布的初步第二季度销售数据不及预期。
据报道，RxSight将2025年销售额预期从此前的1.6亿美元至1.75亿美元区间，大幅下调至1.2亿美元至1.3亿美元之间。这一调整幅度超过25%，远低于分析师平均预期的1.676亿美元。同时，公司预计第二季度初步销售额约为3360万美元，显著低于分析师预计的3980万美元。
摩根大通分析师对此表示担忧，认为这反映出上季度首次出现的负面趋势持续恶化，而非改善。他们指出，这一趋势可能会持续到下半年，目前尚未看到明确的解决方案。这一系列消息引发了投资者对RxSight未来增长前景的担忧，导致股价大幅下挫。截至目前，RxSight股价今年累计下跌已超过60%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.